FDA Approves Sickle Cell Gene Therapy for Young Kids

[ad_1]

(MedPage Today) — The FDA on Wednesday expanded the approval for exagamglogene autotemcel (exa-cel, Casgevy) in severe sickle cell disease with recurrent vaso-occlusive crises and transfusion-dependent beta thalassemia to include children 2 years…

[ad_2]

Source link : https://www.medpagetoday.com/hematologyoncology/hematology/122035

Author :

Publish date : 2026-07-02 16:08:00

Copyright for syndicated content belongs to the linked Source.